In the latest session, ATAI Life Sciences N.V. (NASDAQ: ATAI) closed at $2.30 down -6.88% from its previous closing price of $2.47. On the day, 1628821 shares were traded.
Ratios:
For a deeper understanding of ATAI Life Sciences N.V.’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 9.22 and its Current Ratio is at 9.22. In the meantime, Its Debt-to-Equity ratio is 0.07 whereas as Long-Term Debt/Eq ratio is at 0.07.
On November 01, 2022, Loop Capital started tracking the stock assigning a Buy rating and target price of $18.
On November 30, 2021, Maxim Group started tracking the stock assigning a Buy rating and target price of $25.Maxim Group initiated its Buy rating on November 30, 2021, with a $25 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Apr 02 ’24 when Rao Srinivas sold 61,640 shares for $1.85 per share. The transaction valued at 114,034 led to the insider holds 113,360 shares of the business.
Kirpekar Sahil sold 35,801 shares of ATAI for $66,232 on Apr 02 ’24. The Chief Business Officer now owns 64,199 shares after completing the transaction at $1.85 per share. On Apr 02 ’24, another insider, Johnson Anne Nagengast, who serves as the Chief Financial Officer of the company, sold 27,410 shares for $1.85 each. As a result, the insider received 50,708 and left with 73,590 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 1231.84 while its Price-to-Book (P/B) ratio in mrq is 1.57.
Stock Price History:
Over the past 52 weeks, ATAI has reached a high of $2.85, while it has fallen to a 52-week low of $1.02.
Shares Statistics:
A total of 166.03M shares are outstanding, with a floating share count of 115.49M. Insiders hold about 30.44% of the company’s shares, while institutions hold 8.22% stake in the company.
Earnings Estimates
There are RTAI different market analysts currently analyzing its stock. The consensus estimate for the next quarter is $24.78, with high estimates of $51.64 and low estimates of $2.30.
